Conditions: minus 20 °C · liraglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and monographs…
Unanswered questions
Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
I am comparing three suppliers on documentation rather than on price. The figures are clear enough; the question is what they mean and what they do not. I can supply…
The specifics, since they change the answer: liraglutide · ten days. I would like the arithmetic checked rather than the conclusion asserted. I have deliberately not…
Concretely: orforglipron · room temperature · forty-two days. I am trying to build something sustainable rather than something thorough that I will abandon. I have…
What I have: Homopeptide · Guangzhou JEEP Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
What I am working with: semaglutide · STEP 4. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Stated plainly: Medutest · Janoshik · liraglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The case in front of me: 6.67 mg/mL · tirzepatide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that,…
Setup, so nobody has to ask: early satiety · a GLP-1 receptor agonist. The empirical answer seems settled. The explanation does not. If the honest answer is that…
I am asking mechanistically rather than practically — I want the model, not the protocol. This should be a straightforward calculation and I keep getting two…
I have photographs before and after reconstitution if the visual detail matters. The failure mode I am trying to avoid is making this decision emotionally. I have…
For reference: STEP 2 · nausea. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
What I am working with: TSH · six weeks · liraglutide. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the…
For reference: an HPLC purity test · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I would rather over-plan the first cycle and simplify later. I am prepared…
The clinician who ordered the panel was not concerned; I would still like to understand it. The figures are clear enough; the question is what they mean and what they…
Conditions: 96.4% · a C4 column · dulaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The specifics, since they change the answer: liraglutide · 10 mg/mL. I am at the decision point and I would rather think it through than improvise. I would rather…
I have read the medicinal chemistry paper and the pharmacology paper, which helped and did not finish the job. I am trying to choose between two options that are…
Conditions: Suzhou · Norway. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
The case in front of me: nausea · oral semaglutide · PIONEER-1. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
The particulars: date of analysis · QST. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping rules,…
What I am working with: 5 mg · 8 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My working so far, for the…
Setup, so nobody has to ask: orforglipron · 30 °C · forty-two days. I am trying to build something sustainable rather than something thorough that I will abandon. I…